Michael Toepker1, Franklin Kuehas2, Daniela Kienzl3, Ralf Herwig2, Elisa Spazierer3, Bernhard Krauss4, Michael Weber3, Christian Seitz2, Helmut Ringl3. 1. Department of Radiology, Medical University Vienna, Vienna General Hospital, Vienna, Austria. Electronic address: michael.toepker@meduniwien.ac.at. 2. Department of Urology, Medical University Vienna, Vienna General Hospital, Vienna, Austria. 3. Department of Radiology, Medical University Vienna, Vienna General Hospital, Vienna, Austria. 4. Healthcare Sector, Siemens AG, Forchheim, Germany.
Abstract
PURPOSE: We evaluated a dual energy, split bolus computerized tomography protocol that provides virtual noncontrast, parenchymal and urographic phases in a single scan. We assessed the sensitivity of the virtual noncontrast phase using this protocol to detect urinary stones compared to the gold standard of the true noncontrast phase. MATERIALS AND METHODS: We prospectively enrolled in the study 81 patients who underwent unenhanced single energy computerized tomography at 120 kV/200 mA as well as contrast enhanced dual energy computerized tomography on a Somatom® Definition Flash-CT (tube A 80 kV/233 mA and tube B SN 140 kV/180 mA with 1/0.8 mm slice thickness). For the split bolus protocol 400 mg/ml Iomeron® were injected at 2 time points, that is 15 ml 10 minutes before the scan and 80 ml 65 seconds before the scan. In a consensus reading 2 readers evaluated the presence and diameter of stones on the true and virtual noncontrast phases. RESULTS: Of the 350 stones noted on the true noncontrast phase we found 289 on the virtual noncontrast phase as well as 13 false-positive and 66 false-negative stones. Sensitivity was 98.4%, 89.8% and 82.6% per patient, segment and stone, respectively. The diameter measured on the virtual noncontrast phase corresponded to a mean ± SD 92.5% ± 31.6% of the diameter on the true noncontrast phase. The mean effective dose was 4.8 ± 1.8 and 10.5 ± 3.7 mSv for the true and virtual noncontrast phases, respectively. CONCLUSIONS: The proposed protocol allows for combining 3 phases in a single scan while still enabling the detection of urinary stones at high sensitivity. This technique halves the radiation dose and provides the surgeon with better anatomical information on the calyceal system. Therefore, it is a valuable diagnostic tool for kidney stone treatment planning and followup.
PURPOSE: We evaluated a dual energy, split bolus computerized tomography protocol that provides virtual noncontrast, parenchymal and urographic phases in a single scan. We assessed the sensitivity of the virtual noncontrast phase using this protocol to detect urinary stones compared to the gold standard of the true noncontrast phase. MATERIALS AND METHODS: We prospectively enrolled in the study 81 patients who underwent unenhanced single energy computerized tomography at 120 kV/200 mA as well as contrast enhanced dual energy computerized tomography on a Somatom® Definition Flash-CT (tube A 80 kV/233 mA and tube B SN 140 kV/180 mA with 1/0.8 mm slice thickness). For the split bolus protocol 400 mg/ml Iomeron® were injected at 2 time points, that is 15 ml 10 minutes before the scan and 80 ml 65 seconds before the scan. In a consensus reading 2 readers evaluated the presence and diameter of stones on the true and virtual noncontrast phases. RESULTS: Of the 350 stones noted on the true noncontrast phase we found 289 on the virtual noncontrast phase as well as 13 false-positive and 66 false-negative stones. Sensitivity was 98.4%, 89.8% and 82.6% per patient, segment and stone, respectively. The diameter measured on the virtual noncontrast phase corresponded to a mean ± SD 92.5% ± 31.6% of the diameter on the true noncontrast phase. The mean effective dose was 4.8 ± 1.8 and 10.5 ± 3.7 mSv for the true and virtual noncontrast phases, respectively. CONCLUSIONS: The proposed protocol allows for combining 3 phases in a single scan while still enabling the detection of urinary stones at high sensitivity. This technique halves the radiation dose and provides the surgeon with better anatomical information on the calyceal system. Therefore, it is a valuable diagnostic tool for kidney stone treatment planning and followup.
Authors: Rolf Symons; Bernhard Krauss; Pooyan Sahbaee; Tyler E Cork; Manu N Lakshmanan; David A Bluemke; Amir Pourmorteza Journal: Med Phys Date: 2017-08-20 Impact factor: 4.071
Authors: Maria A Jepperson; El-Sayed H Ibrahim; Abby Taylor; Joseph G Cernigliaro; William E Haley; David D Thiel Journal: Urology Date: 2014-07-15 Impact factor: 2.649
Authors: Dermot O'Kane; Frank T D'Arcy; Nathan Papa; Neil Smith; Scott McClintock; Nathan Lawrentschuk; Damien M Bolton Journal: Investig Clin Urol Date: 2016-02-29